olivLaw · US equity research
Plexus Corp. PLXS
Printed Circuit Boards · SIC 3672 · Vertical: Printed Circuit Boards (SIC 3672)
Plexus Corp. designs, manufactures and services complex products for the aerospace and defense, healthcare and life sciences, and industrial sectors, operating under demanding regulatory regimes. It matters now because revenue accelerated sharply in the third quarter of fiscal 2026, to above 1.3 billion USD.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Plexus Corp. (PLXS) stock was 206.72 USD (−4.64% on the day), with market capitalisation 5.5 bn USD, P/E 30.5 on diluted EPS of 6.78 USD over the last 12 months, beta 1.41, 52-week range 132.74–303.82 USD. Latest reported quarter (Q3 2026): revenue of 1.3 m USD (+28.1% YoY), net income of 43.0 m USD (−4.7% YoY), diluted EPS 1.58 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 34.9
- weak (30–45)
- Bollinger (20, 2)
- 197.65 – 267.37
- in the lower half of the band · %B 0.13 · band width 30.0%
- SMA 50 / 200
- 245.04 / 240.82
- mixed trend
- MACD (12, 26, 9)
- -11.42 / -9.11
- MACD below signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | −24.3% | −1.1% | −23.2 pp | — |
| 3 months | −24.7% | −0.5% | −24.3 pp | — |
| 6 months | −22.0% | +4.4% | −26.4 pp | — |
| Year to date | +40.6% | +12.3% | +28.3 pp | — |
| 1 year | +48.2% | +13.5% | +34.7 pp | −7.9% |
| 3 years | +108.7% | +76.4% | +32.3 pp | +124.2% |
| 5 years | +118.8% | +63.7% | +55.1 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q3 2026 · 04 Jul 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.0 bn | 976.1 k | 980.2 k | 1.0 m | 4.0 bn | 1.1 m | 1.2 m | 1.3 m |
| Cost of revenue | 942.7 m | 875.4 m | 882.4 m | 915.0 m | 953.6 m | 963.7 m | 1.0 bn | 1.2 bn |
| Gross profit | 107.9 m | 100.7 m | 97.8 m | 103.3 m | 104.8 m | 106.1 m | 119.2 m | 131.4 m |
| SG&A | 54.1 m | 49.1 m | 49.0 m | 49.7 m | 51.7 m | 51.7 m | 57.3 m | 70.1 m |
| Operating income | 53.9 m | 46.9 m | 48.8 m | 53.6 m | 53.1 m | 54.5 m | 61.8 m | 61.3 m |
| Depreciation & amortisation | 19.6 m | 19.4 m | 19.5 m ≈ | 19.6 m ≈ | 19.3 m | 19.2 m | 19.3 m ≈ | 18.9 m ≈ |
| Interest expense | 5.6 m | 3.6 m | 3.1 m | 2.5 m | 2.4 m | 2.9 m | 3.4 m | 4.1 m |
| Pre-tax income | 45.4 m | 43.5 m | 45.0 m | 49.8 m | 49.7 m | 51.0 m | 57.9 m | 56.4 m |
| Income tax | 4.2 m | 6.2 m | 6.0 m | 4.7 m | -1.8 m | 9.9 m | 8.1 m | 13.5 m |
| Net income | 41.2 m | 37.3 m | 39.1 m | 45.1 m | 51.4 m | 41.2 m | 49.8 m | 43.0 m |
| Diluted EPS | 1.48 ≈ | 1.34 | 1.41 | 1.64 | 1.87 ≈ | 1.51 | 1.82 | 1.58 |
| Operating cash flow | 220.1 m | 53.6 m | 36.7 m ≈ | 26.9 m ≈ | 132.0 m | -15.4 m | 28.5 m ≈ | 25.9 m ≈ |
| Capex | 26.3 m | 26.5 m | 20.2 m ≈ | 13.7 m ≈ | 34.8 m | 35.2 m | 12.5 m ≈ | 26.7 m ≈ |
| Share repurchases | 19.5 m | 12.8 m | 12.5 m ≈ | 18.4 m ≈ | 21.5 m | 22.4 m | 21.0 m ≈ | 20.6 m ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Today's P/E sits at the 89 percentile of its own 36-quarter history (min 12.4, median 19.1, max 139.3; quarters with earnings only).
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9 bn | 3.3 bn | 3.5 bn | 3.5 bn | 3.9 bn | 4.2 bn | 4.0 bn | 4.0 bn |
| Revenue YoY | +13.7% | +14.7% | +6.2% | −0.6% | +12.8% | +7.2% | −5.9% | +1.8% |
| Net income | 13.0 m | 108.6 m | 117.5 m | 138.9 m | 138.2 m | 139.1 m | 111.8 m | 172.9 m |
| Net income YoY | −88.4% | +732.9% | +8.2% | +18.2% | −0.5% | +0.6% | −19.6% | +54.6% |
| Diluted EPS | 0.38 | 3.50 | 3.93 | 4.76 | 4.86 | 4.95 | 4.01 | 6.26 |
| Diluted EPS YoY | −88.3% | +821.1% | +12.3% | +21.1% | +2.1% | +1.9% | −19.0% | +56.1% |
| net % | 0.5% | 3.3% | 3.4% | 4.0% | 3.5% | 3.3% | 2.8% | 4.3% |
| Free cash flow | 4.1 m | 24.7 m | 160.3 m | 85.5 m | -127.9 m | 61.8 m | 341.3 m | 154.0 m |
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 27 Sept 2025
- Cash
- 306.5 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 1.5 bn USD
- Total assets
- 3.1 bn USD
- Debt / equity
- unavailable
- Current ratio
- 1.58x
- ROE
- 12.4%
- ROA
- 5.5%
- FCF margin
- 3.8%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 3.5 bn | 3.5 bn | 3.9 bn | 4.2 bn | 4.0 bn | 4.0 bn | SEC (XBRL)· 14 Nov 2025verified |
| Cost of revenue | 3.1 bn | 3.0 bn | 3.5 bn | 3.8 bn | 3.6 bn | 3.6 bn | SEC (XBRL)· 14 Nov 2025verified |
| Gross profit | 312.7 m | 323.3 m | 347.2 m | 394.6 m | 378.5 m | 406.5 m | SEC (XBRL)· 14 Nov 2025verified |
| SG&A | 153.3 m | 143.8 m | 167.0 m | 175.6 m | 190.5 m | 199.5 m | SEC (XBRL)· 14 Nov 2025verified |
| Operating income | 153.4 m | 176.3 m | 178.2 m | 195.8 m | 167.7 m | 202.4 m | SEC (XBRL)· 14 Nov 2025verified |
| Depreciation & amortisation | 56.7 m | 61.0 m | 62.7 m | 69.8 m | 77.8 m | 77.8 m | SEC (XBRL)· 14 Nov 2025verified |
| EBITDA | 210.1 m ≈ | 237.3 m ≈ | 240.9 m ≈ | 265.6 m ≈ | 245.6 m ≈ | 280.2 m ≈ | SEC (XBRL)· 14 Nov 2025derived |
| Interest expense | 16.2 m | 14.3 m | 15.9 m | 31.5 m | 28.9 m | 11.6 m | SEC (XBRL)· 14 Nov 2025verified |
| Pre-tax income | 135.4 m | 160.4 m | 158.3 m | 161.0 m | 129.5 m | 188.0 m | SEC (XBRL)· 14 Nov 2025verified |
| Income tax | 17.9 m | 21.5 m | 20.1 m | 21.9 m | 17.7 m | 15.1 m | SEC (XBRL)· 14 Nov 2025verified |
| Net income | 117.5 m | 138.9 m | 138.2 m | 139.1 m | 111.8 m | 172.9 m | SEC (XBRL)· 14 Nov 2025verified |
| Diluted EPS | 3.93 | 4.76 | 4.86 | 4.95 | 4.01 | 6.26 | SEC (XBRL)· 14 Nov 2025verified |
| Weighted average diluted shares | 29.9 m | 29.2 m | 28.4 m | 28.1 m | 27.9 m | 27.6 m | SEC (XBRL)· 14 Nov 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 385.8 m | 270.2 m | 274.8 m | 256.2 m | 345.1 m | 306.5 m | SEC (XBRL)· 14 Nov 2025verified |
| Receivables | 482.1 m | 519.7 m | 737.7 m | 661.5 m | 622.4 m | 656.6 m | SEC (XBRL)· 14 Nov 2025verified |
| Inventories | 763.5 m | 972.3 m | 1.6 bn | 1.6 bn | 1.3 bn | 1.2 bn | SEC (XBRL)· 14 Nov 2025verified |
| Current assets | 1.8 bn | 1.9 bn | 2.8 bn | 2.7 bn | 2.5 bn | 2.4 bn | SEC (XBRL)· 14 Nov 2025verified |
| Property, plant & equipment, net | 383.7 m | 395.1 m | 444.7 m | 492.0 m | 501.1 m | 546.1 m | SEC (XBRL)· 14 Nov 2025verified |
| Total assets | 2.3 bn | 2.5 bn | 3.4 bn | 3.3 bn | 3.2 bn | 3.1 bn | SEC (XBRL)· 14 Nov 2025verified |
| Accounts payable | 516.3 m | 635.0 m | 805.6 m | 646.6 m | 606.4 m | 726.6 m | SEC (XBRL)· 14 Nov 2025verified |
| Current liabilities | 1.0 bn | 1.1 bn | 2.0 bn | 1.8 bn | 1.6 bn | 1.5 bn | SEC (XBRL)· 14 Nov 2025verified |
| Total liabilities | 1.3 bn | 1.4 bn | 2.3 bn | 2.1 bn | 1.8 bn | 1.7 bn | SEC (XBRL)· 14 Nov 2025verified |
| Equity | 977.5 m † | 1.0 bn † | 1.1 bn † | 1.2 bn † | 1.3 bn † | 1.5 bn † | SEC (XBRL)· 14 Nov 2025verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 210.4 m | 142.6 m | -26.2 m | 165.8 m | 436.5 m | 249.2 m | SEC (XBRL)· 14 Nov 2025verified |
| Capex | 50.1 m | 57.1 m | 101.6 m | 104.0 m | 95.2 m | 95.3 m | SEC (XBRL)· 14 Nov 2025verified |
| Free cash flow | 160.3 m ≈ | 85.5 m ≈ | -127.9 m ≈ | 61.8 m ≈ | 341.3 m ≈ | 154.0 m ≈ | SEC (XBRL)· 14 Nov 2025derived |
| Investing cash flow | -49.9 m | -57.0 m | -101.6 m | -93.3 m | -94.9 m | -95.6 m | SEC (XBRL)· 14 Nov 2025verified |
| Financing cash flow | -1.5 m | -203.9 m | 139.3 m | -92.7 m | -255.6 m | -196.4 m | SEC (XBRL)· 14 Nov 2025verified |
| Share repurchases | 41.4 m | 108.5 m | 50.4 m | 40.9 m | 55.7 m | 65.3 m | SEC (XBRL)· 14 Nov 2025verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
4 indicators that do not apply to the sector.
Valuation
olivLaw classification
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 5.5 bn USD
Key indicators
Coverage and freshness
Score by group
77% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/Salesunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| Gross margin · Quality | 11.4% | 0 (on a fixed band) | 14% |
| EBIT margin · Quality | 5.7% | 73 (vs peers) | 11% |
| FCF margin · Quality | 1.5% | 6 (on a fixed band) | 11% |
| Revenue CAGR 3Y · Growth | 0.9% | 4 (on a fixed band) | 22% |
| Revenue growth (YoY) · Growth | 1.8% | 27 (vs peers) | 11% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Current ratio · Balance sheet | 1.5x | 40 (on a fixed band) | 8% |
| EV/Sales · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | 1.1% | 22 (on a fixed band) | 17% |
| Shareholder yield (distributions) · Returns | 1.6% | 59 (on a fixed band) | 6% |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet· partial40/100 · 1/2 factors with a value
- Growth11/100 · 2/2 factors with a value
- Quality24/100 · 3/3 factors with a value
- Returns59/100 · 1/1 factors with a value
- Valuation· partial22/100 · 1/2 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
PLEXUS CORP. (PLXS). Latest full fiscal year: 2025; data up to 2026-07-04.
Figures computed from the financial statements: revenue 4.0 bn USD in 2025; YoY growth 1.8%; net margin 4.6%; ROE 12.6%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- EBIT margin: 5.7%
What contradicts it
- Gross margin: 11.4%
- FCF margin: 1.5%
- Revenue CAGR 3Y: 0.9%
- Revenue growth (YoY): 1.8%
- FCF yield: 1.1%
Not assessed (insufficient data or a ratio without meaning): Net debt / EBITDA, EV/Sales.
Versus the vertical median
Printed Circuit Boards (SIC 3672) · same industry (4-digit SIC) · compared with 11 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| CLSCelestica Inc. | 29.8 bn | 22.4 | 30.2% | 6.8% | +28.5% | −31% / +777% |
| FLEXFlex Ltd. | 28.5 bn | 27.9 | 19.1% | 3.4% | +8.1% | +31% / +303% |
| JBLJabil Inc | 26.6 bn | 26.5 | 66.7% | 2.9% | +20.6% | +23% / +124% |
| TTMITtm Technologies, Inc. | 7.7 bn | 29.3 | 14.3% | 7.0% | +19.0% | +5% / +389% |
| SANMSanmina Corporation | 7.7 bn | 25.7 | 11.8% | 2.4% | +7.4% | −8% / +187% |
| PLXSPlexus Corp. | 5.5 bn | 30.5 | 12.6% | 4.6% | +1.8% | +48% / +109% |
| BHEBenchmark Electronics, Inc. | 2.3 bn | 42.2 | 5.0% | 1.9% | +0.1% | +45% / +162% |
| CTSCts Corporation | 1.8 bn | 24.4 | 13.0% | 12.9% | +5.2% | +46% / +60% |
| KEKimball Electronics, Inc. | 619.8 m | 22.9 | 4.8% | 2.0% | −3.7% | −11% / +5% |
| NNDMNano Dimension Ltd. | 278.3 m | — | -28.7% | -135.2% | +77.3% | −25% / −43% |
| ELTKEltek Ltd. | 42.0 m | 52.1 | 1.9% | 1.6% | +11.3% | −27% / −49% |
| KTCCKey Tronic Corp | 16.2 m | — | -51.3% | -12.4% | −17.4% | −44% / −64% |
1- and 3-year price returns: for PLXS from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | 120.76 Total return -42% · Per year -42% | 213.89 Total return 3% · Per year 3% | 322.70 Total return 56% · Per year 56% |
| 3 years | 108.84 Total return -47% · Per year -19% | 217.69 Total return 5% · Per year 2% | 361.81 Total return 75% · Per year 21% |
| 5 years | 98.10 Total return -53% · Per year -14% | 221.57 Total return 7% · Per year 1% | 405.65 Total return 96% · Per year 14% |
- Exit P/E± 54.42
- Net margin± 38.10
- Annual revenue growth± 32.39
- Annual dilution± 3.20
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (28 Oct 2026 · results).
In brief
Plexus Corp. designs, manufactures and services complex products for the aerospace and defense, healthcare and life sciences, and industrial sectors, operating under demanding regulatory regimes. It matters now because revenue accelerated sharply in the third quarter of fiscal 2026, to above 1.3 billion USD 3.
SWOT
Strengths
- Plexus offers an integrated solution across the full product lifecycle, from design to services, which supports its position in sectors with complex regulatory requirements.
- Improved operational efficiency and cash cycle performance have supported margins and return on invested capital in recent quarters.
- A global presence across several continents gives flexibility in allocating production and managing customer relationships.
Weaknesses
- Margins are thin, and fixed costs and working capital investment can weigh on results when demand is weak.
- Revenue concentration in a small number of customers increases vulnerability to losing a major program or client.
- The company has no proprietary products, which limits protection of differentiation against competitors.
Opportunities
- A record pipeline of qualified manufacturing opportunities could support revenue growth if converted into launched programs.
- Demand in aerospace and defense and in semiconductor capital equipment could grow, opening new growth paths.
- If operational efficiency holds, margins could advance, supporting the long-term return objective.
Threats
- Dependence on a few customers could expose the company to abrupt order reductions.
- Competitive pressure from providers with greater resources could reduce prices and margins.
- Regulatory changes, tariffs and trade restrictions could limit certain products or markets.
Risks
- Customer concentrationhigh
A small number of customers generates most sales, and losing a major customer could quickly affect results.
- Lack of long-term commitmentshigh
Customers usually do not give firm long-term orders, and demand can be changed or cancelled, which complicates planning.
- Component supplymedium
Component shortages and long lead times can raise costs and delay production.
- Regulation and compliancemedium
Requirements for medical devices, defense and international trade change quickly, and non-compliance can lead to sanctions.
- Free cash flowmedium
Rapid revenue growth requires working capital investment, and the company expects a usage of free cash flow in fiscal 2026 3.
Investment thesis
What would need to be true (bull case)
- Accelerated revenue growth, supported by new program launches and a record pipeline, could strengthen the company's position over the medium term.
- Better return on invested capital and cash cycle performance show operational progress that could sustain margins if it holds.
- Diversification across three sectors and three regions could reduce the impact of a slowdown in any single area.
What would break the thesis
- Margins remain thin, and rapid revenue growth can absorb working capital and leave free cash flow negative in fiscal 2026.
- Dependence on a small group of customers could amplify the effect of abrupt order cuts or the loss of a client.
- Competition and price pressure from providers with greater resources could limit long-term margin expansion.
What to watch
- Pace of new program launches and delivery against fourth-quarter revenue guidanceQ4 2026
- Return to positive free cash flow, indicated as possible in early fiscal 2027early fiscal 2027
- Trend in the share of revenue from the 10 largest customersnext 10-K
- Achievement of the 9-12% long-term revenue growth goal, particularly in fiscal 20272027
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 06 Aug 2026; since then the company filed 8-K (28 Oct 2026 · results).
The business
Plexus provides integrated solutions across the full product lifecycle: design and development, supply chain solutions, new product introduction, manufacturing and sustaining services 1. It works mainly on a turnkey basis, in which the company procures and warehouses all materials, and some solutions use consignment 1. The company does not make its own proprietary products; it assembles products for customers 1.
The business depends on a small number of customers: the 10 largest accounted for 49.1% of net sales in fiscal 2025 1. In the third quarter of fiscal 2026, the top 10 represented 55% of revenue 3. The company reports results by geographic segment (AMER, APAC, EMEA), while it manages business development by market sector 1.
Segments
Market context
Trends
- Stronger demand in industrial and semiconductor equipmenttailwind
Stronger end-market demand and new program launches supported revenue in the third quarter of fiscal 2026 3. If this trend holds, it could support revenue growth over the medium term.
- Cash cycle and working capitalmixed
The cash cycle fell to 62 days in the third quarter of fiscal 2026 3. However, rapid revenue growth requires further working capital investment, so the company expects a usage of free cash flow in fiscal 2026 3.
- Dependence on large customersheadwind
Customer concentration remains a feature of the business: the 10 largest customers rose from 49.1% to 55% of revenue within a few quarters 13. Losing or significantly reducing orders from a major customer could affect results considerably.
- Regulation and trade pressuresheadwind
Regulatory requirements for medical devices, defense and international trade are growing more complex, and tariffs and export restrictions can limit certain activities 12. These factors could reduce margins or demand if they worsen.
Competitive position
Plexus operates in a highly competitive market with global and regional providers, as well as customers' in-house capabilities 1. Larger competitors may have more purchasing power for components, greater resources or lower internal costs 1. The company argues its edge lies in a full range of lifecycle services and its global footprint 1.
Competition also comes from smaller providers specialized by sector or region, and from manufacturers serving high-volume, less complex products 1. The cost gap against those players is wider for Plexus, due to lower volumes and stricter regulatory requirements 1.
- Global electronics manufacturing services providers
Providers with global operations, greater name recognition and larger resources, referred to generically in the source; specific firms are not named in the texts provided.
- Regional and local providers
Smaller companies competing in specific sectors and limited geographies, with no names given in the sources.
- Customers' in-house capabilities
Customers who choose to design, manufacture or service products themselves, an alternative to outsourcing.
- High-volume manufacturers
Providers serving high-volume, less complex products where the company's cost structure is comparatively higher.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Plexus Director Karen Rapp Sells 500 Shares for $120,400Yahoo Finance — News · 12 Sept 2026 · EN
- Producătorul de componente electronice Plexus din Oradea a revenit pe profit în 2025, la afaceri de peste 1,5 mld. leiZiarul Financiar · 10 Jul 2026 · RO
The latest news item in our archive is from 12 Sept 2026; the newest SEC filing is from 28 Oct 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.
SEC filings
- Current report28 Oct 2026Results of operations · Financial statements and exhibits
- Current report24 Aug 2026Other events · Financial statements and exhibits
- Quarterly report06 Aug 2026
- Current report29 Jul 2026Results of operations · Financial statements and exhibits
- Current report08 Jun 2026Material agreement · Creation of a direct financial obligation · Financial statements and exhibits
- Quarterly report07 May 2026
- Current report29 Apr 2026Results of operations · Departure or appointment of officers · Financial statements and exhibits
- Current report19 Feb 2026Shareholder vote · Financial statements and exhibits
- Quarterly report05 Feb 2026
- Current report28 Jan 2026Results of operations · Financial statements and exhibits
Sources
- [1] Form 10-K, fiscal year ended 2025-09-27 · SEC / Plexus Corp. · 14 Nov 2025
- [2] Form 10-Q, quarter ended 2026-07-04 · SEC / Plexus Corp. · 06 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Plexus Corp. · 29 Jul 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.